The United Kingdom has approved another Coronavirus vaccine for use, the CNN has reported.
The Country which has lately become the epicentre of the new strain of the virus, is the first in the world to start inoculating its Citizens.
The UK government said in a statement that the Medicines and Healthcare Products Regulatory Agency (MHRA) had authorized Oxford University/AstraZeneca’s Covid-19 vaccine following “rigorous clinical trials and a thorough analysis of the data by experts at the MHRA.”
The vaccine had met “strict standards of safety, quality and effectiveness,” according to the statement.
“The NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. It has already vaccinated hundreds of thousands of patients with the Pfizer/BioNTech vaccine and its roll out will continue. Now the NHS will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine.”
Previously, the team developing the vaccine said it had an “an average efficacy of 70 percent” with one closing regiment showing an efficacy of 90 per cent.
“Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply,” Andrew Pollard, chief investigator of the Oxford Vaccine Trial, said in November.
The vaccine — developed at England’s Oxford University — is significantly cheaper than the others and, crucially, it would be far easier to transport and distribute in developing countries than its rivals since it does not need to be stored at freezing temperatures.
“Pfizer and Moderna require freezer storage, and that just isn’t in place in many settings,” Ghani said.